Professional Experience
He has built a distinguished career in clinical oncology and research leadership at UZ Leuven / Leuven Cancer Institute (LKI).
- Current Position: Staff member in General Medical Oncology at UZ Leuven; researcher at the Laboratory of Experimental Oncology, Leuven Cancer Institute (LKI)
- Previous Roles:
- Staff member at Hôpital Européen Georges Pompidou, Paris
- Researcher at INSERM U1162, Université Paris-Descartes
- Leadership Roles:
- Senior academic staff member, Faculty of Medicine, KU Leuven
- Member of the Council of the Department of Oncology, KU Leuven
Academic Contributions
Prof. Dr. Beuselinck is deeply involved in teaching, research, and mentorship within oncology.
- Teaching Positions: Assistant Professor at the Faculty of Medicine, KU Leuven
- Research Interests:
- Renal cell carcinoma and anti-angiogenic therapy
- Immune therapy in cancer
- Psychological aspects of cancer care
- Research Projects:
- Optimization of metastatic renal cell carcinoma treatment with immune checkpoint inhibitors (2025–2029)
- Psychological suffering in cancer patients: meaning in life and end-of-life decisions (2025–2029)
- Stratifying renal carcinoma patients using immune and epithelial landscape profiling (2025–2029)
- Publications: Author of over 267 peer-reviewed articles, cited over 6,000 times
Areas of Expertise
Prof. Dr. Beuselinck specializes in the treatment of renal cancers and other urologic malignancies, offering patient-focused care and advanced therapies.
- Conditions Treated:
- Renal Cell Carcinoma (RCC)
- Clear-Cell Renal Cell Carcinoma (ccRCC)
- Metastatic Renal Cell Carcinoma (mRCC)
- Other urologic cancers
- Patient-Focused Approach: Tailors treatment plans to individual patient needs for optimal outcomes
Publications and Research
His research strengthens his authority in renal oncology and informs clinical practice worldwide.
- Peer-Reviewed Articles:
- Haaker L, et al. “Pseudoprogression and Mixed Responses in Metastatic Renal Cell Carcinoma Patients Treated With Nivolumab.” Clin Genitourin Cancer. 2023;21(4):442-451.
- Roussel E, et al. “Molecular underpinnings of glandular tropism in metastatic clear cell renal cell carcinoma: therapeutic implications.” Acta Oncol. 2021;60(9):1189-1196.
- Kinget L, et al. “MicroRNA expression profiles in molecular subtypes of clear-cell renal cell carcinoma are associated with clinical outcome.” Acta Oncol. 2020;59(10):1303-1311.
- Research Profiles:
- ResearchGate: 267+ publications, 6,000+ citations
- ORCID: 0000-0001-7427-9102
Patient Care Philosophy
He emphasizes empathy, clear communication, and personalized oncology care for every patient.
- Communication: Ensures patients and families understand treatment plans and options
- Patient Education: Provides detailed information to empower informed decisions
- International Patients: Available for consultations and collaboration
- Cultural Sensitivity: Respects diverse patient backgrounds and needs
Professional Affiliations
Prof. Dr. Beuselinck’s memberships and certifications demonstrate his professional recognition and expertise.
- National:
- Member of the Council of the Faculty of Medicine, KU Leuven
- Member of the Council of the Department of Oncology, KU Leuven
- International:
- Invited researcher at INSERM, Paris
- Collaborator with international oncology research institutions
- Certifications:
- Board-certified Medical Oncologist (Belgium)
FAQs
- Is Prof. Dr. Benoit Beuselinck board-certified?
- Yes, he is a board-certified Medical Oncologist in Belgium.
- What types of surgeries does he perform?
- He specializes in medical oncology and does not perform surgical procedures.
- Does he treat international patients?
- Yes, he is open to consultations and collaborations with international patients.
- How long is the typical hospital stay for RCC treatment?
- Duration varies depending on treatment type; he provides personalized recommendations for each patient.
- What languages does he speak?
- Prof. Dr. Beuselinck is fluent in Dutch, French, and English.
- What is his approach to patient care?
- He prioritizes empathy, clear communication, and patient education for optimal outcomes.
- Where does Prof. Dr. Beuselinck conduct research?
- He conducts research at the Leuven Cancer Institute (LKI) within UZ Leuven.
